Augmedix (AUGX) News Today → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free AUGX Stock Alerts $1.21 -0.02 (-1.63%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 17 at 2:34 AM | americanbankingnews.comB. Riley Analysts Boost Earnings Estimates for Augmedix, Inc. (NASDAQ:AUGX)May 16, 2024 | marketbeat.comBrokers Set Expectations for Augmedix, Inc.'s Q2 2024 Earnings (NASDAQ:AUGX)Augmedix, Inc. (NASDAQ:AUGX - Free Report) - Stock analysts at B. Riley lifted their Q2 2024 earnings estimates for Augmedix in a research report issued to clients and investors on Tuesday, May 14th. B. Riley analyst Y. Zhi now anticipates that the company will earn ($0.12) per share for the quarMay 15, 2024 | benzinga.comLatest News for Augmedix Stock (NASDAQ:AUGX)May 15, 2024 | americanbankingnews.comAugmedix (NASDAQ:AUGX) Downgraded by Maxim Group to "Hold"May 15, 2024 | americanbankingnews.comAugmedix (NASDAQ:AUGX) Stock Rating Lowered by Evercore ISIMay 15, 2024 | americanbankingnews.comAugmedix (NASDAQ:AUGX) PT Lowered to $3.50May 14, 2024 | marketbeat.comAugmedix (NASDAQ:AUGX) Price Target Cut to $3.50 by Analysts at Lake Street CapitalLake Street Capital cut their price objective on shares of Augmedix from $8.00 to $3.50 and set a "buy" rating on the stock in a research report on Tuesday.May 14, 2024 | finanznachrichten.deAugmedix Inc: Augmedix Delivers 40% Revenue Growth for First Quarter of 2024May 14, 2024 | msn.comAugmedix, Inc. (NASDAQ:AUGX) Q1 2024 Earnings Call TranscriptMay 14, 2024 | marketbeat.comAugmedix (NASDAQ:AUGX) Downgraded to Hold at Maxim GroupMaxim Group lowered Augmedix from a "buy" rating to a "hold" rating and set a $5.00 price objective for the company. in a report on Tuesday.May 14, 2024 | investorplace.comWhy Is Augmedix (AUGX) Stock Down 41% Today?May 14, 2024 | finance.yahoo.comAugmedix Inc (AUGX) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amidst ChallengesMay 13, 2024 | globenewswire.comAugmedix Delivers 40% Revenue Growth for First Quarter of 2024May 12, 2024 | marketbeat.comAugmedix, Inc. (NASDAQ:AUGX) Short Interest UpdateAugmedix, Inc. (NASDAQ:AUGX - Get Free Report) was the target of a large growth in short interest in April. As of April 30th, there was short interest totalling 1,690,000 shares, a growth of 36.3% from the April 15th total of 1,240,000 shares. Currently, 3.8% of the company's stock are sold short. Based on an average daily volume of 368,700 shares, the days-to-cover ratio is currently 4.6 days.May 11, 2024 | americanbankingnews.comAugmedix (AUGX) Scheduled to Post Earnings on MondayMay 10, 2024 | marketbeat.comRussell Investments Group Ltd. Acquires 663,778 Shares of Augmedix, Inc. (NASDAQ:AUGX)Russell Investments Group Ltd. increased its holdings in Augmedix, Inc. (NASDAQ:AUGX - Free Report) by 292.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 891,077 shares of the company's stock after purcMay 6, 2024 | marketbeat.comAugmedix (AUGX) Set to Announce Quarterly Earnings on MondayAugmedix (NASDAQ:AUGX) will be releasing earnings after the market closes on Monday, May 13, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=591710)May 3, 2024 | globenewswire.comAugmedix to Participate in Upcoming Investor Conferences in May and June 2024April 30, 2024 | finance.yahoo.comAugmedix to Announce First Quarter 2024 Financial Results on May 13, 2024April 27, 2024 | stockhouse.comAugmedix Awarded on Newsweek's World's Best Digital Health Companies 2024 ListApril 24, 2024 | finance.yahoo.comAugmedix Launches Industry’s First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency DepartmentsApril 24, 2024 | globenewswire.comAugmedix Launches Industry's First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency DepartmentsApril 19, 2024 | investorplace.com3 Penny Stocks That Could Make a Big Comeback by the End of Q2April 17, 2024 | msn.comAugmedix (AUGX) Price Target Decreased by 6.38% to 6.19April 14, 2024 | investing.comAugmedix's chief strategy officer sells shares worth over $369kApril 12, 2024 | finance.yahoo.comInsider Sell: Augmedix Inc's (AUGX) Chief Strategy Officer Ian Shakil Sells 92,787 SharesApril 12, 2024 | insidertrades.comAugmedix, Inc. (NASDAQ:AUGX) Insider Sells $97,377.54 in StockApril 11, 2024 | marketbeat.comInsider Selling: Augmedix, Inc. (NASDAQ:AUGX) Insider Sells 24,778 Shares of StockAugmedix, Inc. (NASDAQ:AUGX - Get Free Report) insider Ian Shakil sold 24,778 shares of the company's stock in a transaction dated Thursday, April 11th. The shares were sold at an average price of $3.93, for a total transaction of $97,377.54. Following the transaction, the insider now owns 3,000 shares in the company, valued at $11,790. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.April 11, 2024 | investing.comAugmedix shares upgraded to Outperform by Evercore ISIApril 10, 2024 | insidertrades.comIan Shakil Sells 37,780 Shares of Augmedix, Inc. (NASDAQ:AUGX) StockApril 10, 2024 | insidertrades.comAugmedix, Inc. (NASDAQ:AUGX) Insider Sells $207,089.61 in StockApril 9, 2024 | markets.businessinsider.comAnalyst Ratings For AugmedixApril 9, 2024 | marketbeat.comEvercore ISI Upgrades Augmedix (NASDAQ:AUGX) to OutperformEvercore ISI upgraded shares of Augmedix from an "in-line" rating to an "outperform" rating and boosted their price objective for the stock from $4.50 to $5.00 in a report on Tuesday.April 9, 2024 | globenewswire.comAugmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual CareApril 5, 2024 | marketbeat.comB. Riley Comments on Augmedix, Inc.'s Q1 2024 Earnings (NASDAQ:AUGX)Augmedix, Inc. (NASDAQ:AUGX - Free Report) - Research analysts at B. Riley issued their Q1 2024 earnings per share estimates for Augmedix in a note issued to investors on Tuesday, April 2nd. B. Riley analyst Y. Zhi expects that the company will earn ($0.12) per share for the quarter. B. Riley haApril 5, 2024 | insidertrades.comAugmedix, Inc. (NASDAQ:AUGX) Insider Ian Shakil Sells 45,906 SharesApril 5, 2024 | finance.yahoo.comAugmedix Inc (AUGX) Chief Strategy Officer Ian Shakil Sells 109,961 SharesApril 4, 2024 | marketbeat.comAugmedix, Inc. (NASDAQ:AUGX) Insider Sells $188,673.66 in StockAugmedix, Inc. (NASDAQ:AUGX - Get Free Report) insider Ian Shakil sold 45,906 shares of the company's stock in a transaction that occurred on Wednesday, April 3rd. The stock was sold at an average price of $4.11, for a total value of $188,673.66. Following the transaction, the insider now directly owns 95,665 shares of the company's stock, valued at approximately $393,183.15. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.April 4, 2024 | globenewswire.comAugmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems NationwideApril 4, 2024 | insidertrades.comAugmedix, Inc. (NASDAQ:AUGX) Insider Sells $230,603.98 in StockApril 4, 2024 | marketbeat.comInsider Selling: Augmedix, Inc. (NASDAQ:AUGX) Insider Sells 58,978 Shares of StockAugmedix, Inc. (NASDAQ:AUGX - Get Free Report) insider Ian Shakil sold 58,978 shares of the stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $3.91, for a total transaction of $230,603.98. Following the transaction, the insider now owns 180,034 shares in the company, valued at $703,932.94. The sale was disclosed in a filing with the SEC, which is available through the SEC website.April 2, 2024 | insidertrades.comAugmedix, Inc. (NASDAQ:AUGX) Insider Ian Shakil Sells 31,994 SharesMarch 24, 2024 | seekingalpha.comAugmedix: Secular AI Tailwinds, But Still Unattractive Risk-RewardMarch 23, 2024 | finance.yahoo.comAugmedix Full Year 2023 Earnings: In Line With ExpectationsMarch 21, 2024 | finance.yahoo.comEarnings Release: Here's Why Analysts Cut Their Augmedix, Inc. (NASDAQ:AUGX) Price Target To US$6.13March 20, 2024 | finance.yahoo.comAugmedix, Inc. (NASDAQ:AUGX) Q4 2023 Earnings Call TranscriptMarch 18, 2024 | benzinga.comRecap: Augmedix Q4 EarningsMarch 18, 2024 | globenewswire.comAugmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023March 17, 2024 | marketbeat.comAugmedix (AUGX) to Release Earnings on MondayAugmedix (NASDAQ:AUGX) will be releasing earnings after the market closes on Monday, March 18, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=572891)March 12, 2024 | globenewswire.comAugmedix Announces New Positive Data and Enhancements to Its Ambient AI Product, Augmedix Go Get Augmedix News Delivered to You Automatically Sign up to receive the latest news and ratings for AUGX and its competitors with MarketBeat's FREE daily newsletter. Email Address 4 Cryptos BETTER than Bitcoin (Ad)Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin Click For My #1 FREE Crypto for 2024 AUGX Media Mentions By Week AUGX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AUGX News Sentiment▼-0.120.42▲Average Medical News Sentiment AUGX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AUGX Articles This Week▼252▲AUGX Articles Average Week Get Augmedix News Delivered to You Automatically Sign up to receive the latest news and ratings for AUGX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NUTX News AMWL News GNTA News CKPT News CARM News GMTX News CDTX News COCH News LENZ News NOTV News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AUGX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Augmedix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
